Use of GOLD Guidelines for COPD Patients in an Out-patient Pulmonary Practice: Implications for a Future Practice Change by Nagel, Kelly
OUT-PATIENT PRACTICE USE OF GOLD GUIDELINES 1 
 
 
Use of GOLD Guidelines for COPD Patients in an Out-patient Pulmonary Practice:  Implications 
for a Future Practice Change 
DNP Final Project 
 
Presented in Partial Fulfillment of the Requirements for the Doctor of Nursing Practice in the 
Graduate School at The Ohio State University 
 
By 
Kelly L. Nagel, MS, RN, BC-FNP 
Graduate Program in Nursing 
 
The Ohio State University 
2016 
 
DNP Final Project Committee 
Gerene Bauldoff, PhD, RN, FCCP, FAACVPR, FAAN 
Kristine Browning, PhD, CNP 
Carolyn Schubert, DNP, CNE, RN-BC 
 
 
 
  
OUT-PATIENT PRACTICE USE OF GOLD GUIDELINES 2 
Acknowledgements  
 I would like to thank my academic advisor Gerene Bauldoff, PhD, RN, FCCP, 
FAACVPR, FAAN for her expedient and stellar support during these past three years in my DNP 
program, her constant encouragement and preemptive guidance has far more than met my 
expectations.  I especially want to thank her for all of her time spent and how she immediately 
focused on my concerns and placing me on the right path, at some very difficult times during this 
program.   I would also like to thank my committee members Carolyn Schubert, DNP, CNE, RN-
BC and Kristine Browning, PhD, CNP for their support with both my Proposal and Final Project, 
they provided excellent guidance and their time during this process.  I will now be able to move 
forward in my practice with a great education and foundation due to the support that I have 
received.   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
OUT-PATIENT PRACTICE USE OF GOLD GUIDELINES 3 
Dedication    
 I would like to dedicate my project to my family.  My husband, Michael helped to start 
me on this journey and supported me throughout these past three years, “you are my rock”.  I 
would not have made it without his love and constant support.  I would also like to thank my 
daughter, Alyssa for always encouraging and supporting me during this journey.  Finally, my 
sister Tammy for always remaining my confidant and as a fellow professional nurse understands 
the grueling yet very rewarding aspects of our careers.       
 To my daughter Amanda, I love and miss you... 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
OUT-PATIENT PRACTICE USE OF GOLD GUIDELINES 4 
Abstract 
Background:  Chronic Obstructive Pulmonary Disease (COPD) is a treatable disease and 
exacerbations from COPD are preventable, but can require hospitalizations, that cause poor 
outcomes for these patients.  The continued increasing costs and burdens of COPD on the current 
health care system are rising significantly; even though there are proven Evidence Based 
Practices (EBP) Global Initiatives for Chronic Obstructive Lung Disease (GOLD) guidelines that 
have been shown to consistently improve COPD patient outcomes and prevent exacerbations. 
Purpose:  The purpose of this DNP quality improvement project was to evaluate the use of the 
adoption of Global Obstructive Lung Disease Initiative (GOLD) recommendations in an out-
patient pulmonary practice (Gold Guidelines (2016 Global Initiative for Chronic Obstructive 
Lung Disease, 2015).   
Project Methods: An EBP-QI approach was used. A three year retrospective review of 120 
COPD patients’ electronic health records (EHRs) provided the source of the quality process data.  
Results:  The records accessed reported an age range of 40 to 89 with mean of 64.83 years. 
COPD severity included Stage II, n=70 (58.3%), Stage III, n=40 (33.3%), and Stage IV, n=10 
(8.3%). The accessed records were closely divided by gender with 61 females (50.8%) and 59 
males (49.2%).  More than 90% of the sample was Caucasian with African-Americans making 
up 6.7% of the records. Smoking status was documented for all records with 61.9% of the 
patients as former smokers and 38.1% current smokers.   All patients had smoking cessation 
options offered to them.     
GOLD recommendations for recommended pharmacological therapy were assessed, and 
revealed that short acting bronchodilators (SABA) were provided to 100% of patients, while 
long-acting anticholinergic bronchodilators (LAMA) were provided to 93.3% of patients.  For 
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those who didn’t received this therapy, rationale was provided in the record. The use of an 
inhaled corticosteroid/long acting beta agonist (ICS/LABA) or separate prescriptions of just the 
ICS or the LABA was provided to 92.5% of patients.   
Pneumococcal vaccines were noted in only 55.1% of patients while influenza vaccines 
were administered to 63.9% of patients. It is possible that vaccinations were not given to the 
remainder due to previous administration and up to date status.  Pulmonary rehabilitation was 
found to only be prescribed in 36.7% of the records.  
The outpatient pulmonary practice providers were able to meet overall GOLD treatment 
recommendations discussed within this project 80% of the time.  Of the 120 patient records 
abstracted, 24 (20%) received all of the treatment recommendations. 
Conclusions and Implications:  While smoking cessation and medication prescription were  
closely aligned with the recommendations, determination of vaccine use was limited by lack of 
information regarding patients’ vaccination status being current or outdated.  The guideline 
recommendation with the lowest compliance was the referral to pulmonary rehabilitation (PR).  
This may be related to younger or less severely ill patients, or the structural limitations of PR 
such as geographical distance to program, cost (related to high co-pays), or access to programs 
during off-peak hours.  
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Chapter One:  Introduction 
Significance of the Problem 
Chronic Obstructive Pulmonary Disease (COPD) is currently the fourth leading cause of 
death world-wide, yet COPD is both preventable and treatable.  The Global Initiative for Chronic 
Obstructive Lung Disease (GOLD) guidelines provide “best practices”  for evaluation, diagnosis, 
and treatment of the disease (2016 Global Initiative for Chronic Obstructive Lung Disease, Inc. 
[GOLD Guidelines], 2015).  High costs and reimbursement penalties that are due to re-
hospitalization of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) 
exacerbations can be significantly decreased by utilizing the GOLD guidelines. 
This Doctor of Nursing Practice (DNP) evidence-based quality improvement (EBQI) 
project collected three years of retrospective data from an out-patient pulmonary practice site to 
evaluate the use of GOLD guidelines from existing COPD patient records.  This EBQI project’s 
analysis and synthesis of those findings was to determine the utilization of  GOLD guidelines in 
this patient population.  Outcome data identified gaps and subsequent underutilization of “best 
practices.” These findings served as a basis to implement a future EBQI practice change.  
The problem of GOLD guidelines underutilization is compelling because COPD affects 
approximately 14% of the adult population in the United States (U.S.) between the ages 40-79.  
According to the GOLD guidelines, COPD is now the fourth leading cause of preventable and 
premature death in the world (2016 Global Initiative for Chronic Obstructive Lung Disease, Inc. 
[GOLD Guidelines], 2015).  By the year 2020, COPD is expected to be the third leading cause of 
death in the U.S. (Lemmens et al., 2013).  Use of GOLD guidelines improves patient outcomes, 
by decreasing COPD patient’s acute exacerbations of COPD (AECOPD), which increase 
mortality and worsen air flow limitations (GOLD, 2015).  Also, a decrease in COPD patients’ 
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hyperinflation, while improving exercise ability and overall health, has been documented and 
established, by utilizing EBP with the Level I Gold guidelines (GOLD, 2015). 
The depth of the problem is illuminated by annual emergency room visits for AECOPD 
within the U.S. that currently attain 1.5 million and hospitalizations that reach 725,000, at a cost 
of up to $60 billion (Feemster & Au, 2015).   Up to 40% of patients hospitalized for AECOPD 
do not receive recommended treatment(s) while in-patient or do not receive needed follow up 
treatment at discharge; with half receiving inappropriate treatment (Feemster & Au, 2015).  
Nearly 23% of 725,000 patients who are hospitalized and discharged with AECOPD 
exacerbations are readmitted within 30 days after discharge (Feemster & Au, 2015).  Reducing 
these AECOPD readmissions without early and appropriate out-patient follow up care is unlikely 
(Feemster & Au, 2015).  As of 2015, U.S. Centers for Medicare and Medicaid Services (CMS) 
policy makers began to penalize both providers and hospital systems for lack of utilization of 
resources and provision of quality care (Feemster & Au, 2015).   
Purpose 
The purpose of this project was to identify gaps in use of out-patient GOLD guidelines 
treatment recommendations, as well as identifying whether a future evidence based quality 
improvement (EBQI) practice change is needed, in order to prevent AECOPD that impacts 
quality of life and survival rates.  The outcomes of this DNP EBQI project will imply whether 
there needs to be improved utilization of GOLD guidelines that will improve quality of life and 
longevity of COPD patients, while decreasing health care costs for systems, patients, and their 
families.  
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PICOT Question 
The focus of this project and literature search is supported by the following clinical 
PICOT question and problem identification:   Among COPD patients with exacerbations 
requiring hospitalizations (P), does implementation of a care bundle consisting of GOLD 
guidelines criteria (I), impact exacerbation which requires hospitalization (C) within the first 30-
60 days after discharge (T)? 
Significance to Nursing and Health Care   
The continued increasing costs and burdens of COPD on the current health care system 
can often be prevented by utilizing Evidence Based Practice (EBP) COPD GOLD guidelines 
(2016 Global Initiative for Chronic Obstructive Lung Disease, 2015).   
Chronic obstructive pulmonary disease is a progressive disease that is preventable, 
treatable and causes premature deaths world-wide.  Most COPD patients are diagnosed at 
moderate to severe stages of their disease.  Interventions focus on symptom management and 
improvement in function and quality of life while also reducing morbidity.  However, due to the 
chronicity of COPD, the disease is lifelong and mortality is the unfortunate ultimate 
consequence.  COPD has a direct relationship between soaring costs and severity of disease due 
to AECOPD and home oxygen use (2016 Global Initiative for Chronic Obstructive Lung 
Disease, 2015).  This is related to the requirement of home oxygen for patients who are 
hypoxemic as the primary intervention to reduce mortality while the severity of the disease leads 
to increasing need for hospitalization.  
Previous studies have identified mortality and lung function as markers for outcomes for 
COPD patients.  A recent meta-analysis by (Feemster & Au, 2015) identifies decreasing quality 
of life after AECOPD to be associated with more rapid decline and mortality for the COPD 
OUT-PATIENT PRACTICE USE OF GOLD GUIDELINES 9 
patient population.  Newer studies have addressed poor quality of care and the need to increase 
interventions to prevent hospital readmissions by introducing maintenance therapy treatments for 
AECOPD (Feemster & Au, 2015).   
Consistency with DNP Essentials 
 This DNP student’s proposed EBQI project fulfills several criteria that will meet the DNP 
Essentials model for advanced practice nursing.  Three key essentials will be utilized for the 
completion of this project (Zaccagnini & Waud White, 2014).   
 DNP Essential II:  Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking will be applied.  The APRN DNP student’s ability to recognize strategies that 
will create quality improvement by identifying potential problems within the practice, will guide 
future practice changes to improve outcomes for COPD patients and the practice. 
 DNP Essential III:  Clinical Scholarship and Analytical Methods for Evidence-Based 
Practice is congruent with this DNP project.  This DNP student’s internal evidence, as a 
practicing APRN with the COPD population for the past 13 years,  identified the strongest 
evidence for the treatment of COPD as Level I meta-analysis, and will evaluate if clinical 
practice guidelines are being utilized within the out-patient specialty practice.  The outcome of 
this EBQI project will provide information that will help to improve the practice’s use of EBP 
for COPD patients.  
 DNP Essential IV:  Information Systems/Technology and Patient Care Technology for 
the Improvement and Transformation of Health Care informed this project in determining 
appropriate outcomes for EBQI project that will lead to potential decisions of practice change.  
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Project Objectives 
This project’s objectives were to COPD patient records for each variable of the GOLD 
guideline treatment recommendations.  Each variable and outcome was measured to guide the 
decision for a future practice change.  Initially all COPD patients within the practice were 
identified by an ICD-9 code, 496.  To avoid confusion for this project’s data collection, the 
recent varying levels of ICD-10 codes for COPD, which were implemented in October, 2015, 
were not queried for this project.  A query was sought for a group of 120 moderate to severe 
COPD (GOLD II-IV) patients; which were identified as the convenience sample.  Demographics 
including age ranges, sex, ethnicity, and payer source of the study group, were compared to the 
entire population of the out-patient practice’s COPD patient population for appropriate 
representation.   
Once an appropriate representative group of patients were identified, an individual 
retrospective chart review was able to identify GOLD II-IV disease level, based on objective 
findings of each patient’s FEV1 percentage (<80) with an FEV1/FVC ratio (<70).  Each 
pharmacologic and non-pharmacologic GOLD guideline treatment recommendation for this 
group of patients was evaluated, as well as the identification of gaps/underutilization of GOLD 
guidelines in their treatment history.  This project identified measurable success of the GOLD 
guidelines best practices along with possible gaps and/or underutilization in “best practice” 
treatment plans.  The underuse of best practices that may be a contributing factor to AECOPD 
and decrease quality of life, and longevity.  
The Iowa Model of Evidence Based Practice 
The appropriate framework for this project incorporated the initial guidance of the IOWA 
Model of Evidence Based Practice to Promote Quality Care (Appendix A) framework (Melnyk 
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& Fineholt-Overholt, 2011, figure 11.3; Titler et al., 2001).  The IOWA Model was chosen due 
to its origin as a practice theory and its relatability to EBP in specific the patient population 
(Moran, Burson, & Conrad, 2014).   
The initial phase of the Iowa Model provides guidance on asking a “problem focused” 
question for process improvement that needed to be asked, for use of GOLD guidelines for the 
COPD population at the out-patient pulmonary practice.  The model guided this DNP 
student/clinician on whether this is a priority for the organization, which is a “yes”, because it is 
one of the primary diagnoses’ seen in the out-patient pulmonary practice.  The next step of the 
model’s algorithm then guides the clinician to form a team (Melnyk & Fineholt-Overholt, 2011, 
figure 11.3; Titler, et al., 2001). This was then completed by getting stakeholder and clinician 
support and approval from the pulmonologist/practice owner, as well as the practice manager, 
who is also the EHR AtheanaNet manager.  Next, as directed by the Iowa Model, Level I EBP 
guidelines, as well as an extensive literature review, were gathered and evaluated for relevancy. 
A critique of data collection of 120 patient’s findings of demographics, COPD disease 
severity, with GOLD guidelines treatment(s) received, were synthesized for a sufficient analysis 
for appropriate decision making for a practice change implementation.  Should there be sufficient 
evidence obtained in the findings, the model then provides guidance to move forth with a 
practice change.  
Health Change Trajectory Model 
Due to the complexity and levels of COPD severity and illness outcomes to be discussed, 
an innovative Health Change Trajectory model (Appendix B) was chosen for this DNP project.  
A Health Change Trajectory model integrates Mishel’s “Uncertainty in Illness” theory and the 
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Corbin and Strauss "Chronic Illness Trajectory” framework that is applicable to levels of disease 
and has practice and global implications for use in chronic disease (Christensen, 2015). 
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Chapter 2:  Review of Literature 
 
Global Obstructive Lung Disease Initiative Guidelines/Best Practices 
Providing the evidence-based GOLD guideline care (GOLD, 2015) in the out-patient 
setting  entails prescribing inhaled corticosteroids (ICSs), long acting bronchodilators (LABAs), 
referral for pulmonary rehabilitation, prescribing prevention vaccinations for influenza and 
pneumonia, along with continued smoking cessation, and early symptom clinical follow up.  The 
guidelines include the following specific recommendations:  
1. Pulmonary rehabilitation referral/physical activity orders for patients with GOLD 
classification of II-IV, based on post bronchodilator FEV1.  
2. Appropriate medication orders for disease and symptom severity in the form of: 
a.) Short acting bronchodilator (SABA) 
b.) Long acting bronchodilator (LABA) 
c.) Inhaled corticosteroid (ICS) 
d.)  ICS combined with a LABA (ICS/LABA) 
e.) Anti-cholinergic meter dosed inhaler (LAMA) or in combination with a long acting 
bronchodilator (LAMA/LABA) 
3.  Vaccination(s) consisting of influenza and/or pneumococcal, with recommended   updates or 
prescription(s) and counseling to obtain these vaccinations.   
4.   Smoking cessation education, counseling, and treatment, with current diagnosis of Chronic 
Tobacco Dependence, at each visit. 
The improvement of chronic care management (CCM) of COPD disease within the out-
patient care setting has shown to improve quality of life and decreased AECOPD (Lemmens et 
al., 2013, p. 734).  Providing and/or improving utilization of GOLD guideline treatment with 
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each guideline every time with every COPD patient would be insured by the use of an out-patient 
COPD Care Bundle (CB). 
Care Bundles are identified by the Institute for Health Care Improvement (IHI) to 
“deliver the best possible care for patients” with three to five Level I Evidence Based Practices 
(EBP) that are followed together as a group for any patient every time.  These (CBs) that include 
EBPs, are performed consistently, every time, and are shown to improve patient care and 
outcomes (Haraden, 2014, p. 1).   
A recent hospital discharge CB for COPD patients was developed in order to improve 
outcomes for COPD patients after an exacerbation.  The teams that were formed for 
implementation of the CB found barriers to their success to be “staff to busy, staff shortages, lack 
of staff engagement, added workload of the bundle, and patient coding issues” (Lennox et al., 
2014, p. 1).  The COPD discharge CB components which included five EBP elements  which 
included smoking cessation assistance, referral to pulmonary rehabilitation,  providing written 
education for COPD self-management, implementation of satisfactory use of inhalers, and 
making a follow up referral and appointment to pulmonary specialty prior to discharging the 
patient.  These EBPs as CB components are outlined within the GOLD guidelines as effective 
management of COPD (GOLD,  2015). 
The Institutes of Medicine (IOM) recently identified six dimensions of care that need to 
be improved to achieve the ideal healthcare system.  These dimensions include improvement of 
patient safety, effective treatment for patients, patient centered care, along with timely, efficient, 
and equitable care ("IOM’s Six Aims," n.d.).   If the GOLD guidelines are not provided by 
initiating and completing a set of known CB practices each and every time a COPD patient is 
seen, there is no consistency and these dimensions of care are not adequately provided.  The 
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COPD patient would have lack of safety and prevention from re-exacerbation of their disease, 
lack of effective treatment that is centered on each patient, their EBP care would not be 
implemented in a timely manner, and the out-patient office would not be able to provide a timely 
and efficient treatment plan.  Equitable care would be negatively affected because of 
inconsistency of care and failure to provide the COPD CB.   
Review of Literature 
  An exhaustive search for literature was completed for the above mentioned PICOT 
question.  The COPD GOLD guidelines that were utilized for the audit questions are written by 
experts in the field and have been updated as of December 2015 (2016 Global Initiative for 
Chronic Obstructive Lung Disease, Inc. [GOLD], 2015).  The GOLD guidelines are a summary 
of the latest world-wide EBP recommendations for COPD.  They include the latest meta-
analyses of randomized control trials (RCT) and therefore are the best Level I EBP available 
(2016 Global Initiative for Chronic Obstructive Lung Disease, 2015). 
The GOLD guidelines provide the presentation of symptoms for a COPD diagnosis.  The 
diagnosis should be considered when a patient presents with chronic cough, complaints of 
shortness of breath (dyspnea), or is producing sputum with his cough.  Any patient with a history 
of smoking and/or exposures (cooking/heating fuels and/or occupational chemicals/dusts), is  
considered at risk for COPD and should have a spirometry test completed.  A spirometry test that 
indicates obstruction of the airways (air flow limitation ratio of an FEV1/FVC <0.70) must be 
obtained.  This spirometry value along with the above mentioned risk factors will verify a 
clinical diagnosis of COPD (GOLD, 2015). 
Symptoms experienced by COPD patients can be mild to severe in nature.  However, 
dyspnea, (a “cardinal” symptom), chronic cough, sputum production, with possible wheezing 
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and feeling a tightness in the chest area are characteristic symptoms of the disease” (GOLD, 
2015).  When spirometry test results show air flow limitations that reach severe to very severe 
stages (GOLD III and IV) with a ratio of FEV1/FEVC <0.50, additional symptoms of cough 
syncope, fatigue, and or weight loss can occur.  An AECOPD is caused by worsening air flows 
and happens acutely.  Having two or more events of AECOPD within one year are considered 
frequent occurrences, which also predict worsening disease and increased risk of death (GOLD, 
2015). 
The best available evidence to guide a clinical question is based on the level of 
evidences’ quality, with the strongest evidence labeled as Level I and the weakest evidence as 
Level VII (Facchiano & Hoffman Snyder, 2012).  Multiple on-line databases that were included 
in the search were Cochrane, Pub Med, CINAHL, EBSCOHost Medline, and Up To Date.  The 
systematic review utilized the Preferred Reporting Items for Systematic Reviews and Meta-
analyses (PRISMA) checklist to appraise the literature (Moher, Liberati, Tetzlaff, & Altman, 
2009).  Outside sources from the 2013-2016 GOLD Guidelines and UpToDate.com were queried 
for the same PICOT vocabulary, revealing multiple hyperlinks within one source to treat COPD, 
reflecting multiple consistent recommendations.  Due to the abundance of studies, best practices 
identified during a Rapid Critical Appraisal (RCA) exercise revealed the need to use Level I 
studies with meta-analysis Cochrane library support.  This decision eliminated the need to review 
multiple articles that may not have produced desired outcomes utilizing the GOLD guideline 
criteria (GOLD, 2015).   
This clinical practice DNP project was guided by the highest EBP available.  Level I 
evidence was synthesized and evaluated in the form of tables.  The literature provided meta-
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analyses of evidenced based clinical practice guidelines developed from randomized controlled 
trials (RCTs) and systematic reviews. 
Level I evidence that included relevant to this DNP project was considered along with the 
evidence of the GOLD guidelines.  A Cochrane systematic review (2013) by Kruis and 
colleagues included 26 RCTs consisting of 2997 COPD patients from 11 countries.  The authors 
analyzed patients with COPD who did, and who did not receive integrated disease management.  
The meta-analysis revealed that integrated disease management (IDM) between providers 
decreased hospital admissions, and hospital days per person (Kruis, et al., 2013).  In 2013, 
Lemmons and colleagues reported a U.S. meta-analysis electronic data base search from 1995 to 
2009 which included nearly 30 studies with the majority of studies being RCT’s, for COPD 
Chronic Care Management (CCM).  They reported that CCM of the COPD patient population 
improved quality of life (QoL), exercise capacity, and decreased hospitalizations for AECOPD 
(Lemmons, et al., 2013).     
Evaluation of the above literature highly suggests that integrated and out-patient 
management improves the COPD patient population’s quality of life, exercise capacity, and 
prevents hospitalizations for AECOPD, which decreases risk of death.  Therefore, this project is 
important to document the impact of GOLD guidelines on an out-patient COPD population to 
prevent hospitalizations for AECOPD.  The GOLD guidelines provided the best EBP for CPG 
for COPD and AECOPD.   
Gaps in evidence existed regarding CCM to decrease hospitalizations without providing 
quality COPD education (Fan et al., 2012).  The RCT study reported 960 adult Veteran 
Administration COPD patients that were entered into a CCM program with nurse educators to 
decrease hospitalizations.  The study was discontinued by the data safety monitoring board after 
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2 years due to an increase in mortality compared with the non-study group (Fan et al., 2012).  A  
Cochrane systematic review by Walter and colleagues (2010) analyzed individualized Action 
Plans focused on oral steroid and antibiotic use for recent AECOPD patients.  The review found 
increased use and dosage of oral steroid and antibiotics.  As this review focused on AECOPD 
patients, it did not inform data selection and collection for this project which focused on the 
general COPD patient.     
Related research 
One small study was reviewed regarding an out-patient QI project on patient and provider 
attributes associated with AECOPD.  The investigators examined 50 electronic health records 
(EHR’s) and found that  CPGs were only documented in 24% of the EHRs, but when CPGs were 
followed there were less AECOPD episodes  (Stanley, Gordon, & Pilon, 2013).  Evidence did 
not identify provider differences between out-patient APRNs and physicians, regarding the use 
of GOLD guidelines and AECOPD incidents.  Recent interests in treating AECOPD in the home 
setting versus the hospital has been developed in randomized studies but has not revealed 
consistent results (Chojnowski, 2003).  A QI project retrospective evaluation of four hospitals 
and a total of 1,052 AECOPD patient records found several challenges of initiating a Level I 
evidence care bundle (CB) that included GOLD guidelines (Lennox, Green, Howe, Musgrave, & 
Bell, 2014).  These challenges were organized along 5 themes: staffing, infrastructure, process, 
use of improvement methodology and patient and public involvement. The authors concluded 
that these challenges can be identified and addressed prior to implementation of changes in care 
processes.  
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Summary  
The GOLD guidelines provide evidence-based recommendations for the diagnosis, 
treatment and management of COPD.  Diagnosis includes use of spirometry to elucidate disease 
severity by stage (Stages I through IV).  Treatment focuses on 4 components: tobacco cessation, 
pharmacological interventions based on stage, vaccinations for pneumonia and influenza to 
prevent these significant morbidities, and, referral to pulmonary rehabilitation (GOLD, 2015).  
Together, these recommendations can be “bundled” to provide evidence-based care in a 
consistent manner (Haraden, 2014).  The use of the project PICOT question drove the search for 
external evidence.  Several meta-analyses (level I evidence) support the use of the interventions 
identified in the GOLD guidelines (Kruis, et al., 2013; Lemmons, et al., 2013). Additional 
literature found (Fan, et al., 2012; Stanley, et al., 2013; Lennox et al., 2014) described issues and 
themes that can impact implementation of practice change.  These environmental and process 
related issues and themes should be addressed prior to practice changes are implemented.  
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Chapter 3:  Methods 
Project Design   
The design for this DNP project utilized an EBQI approach. When seeking to improve 
outcomes using EBP within practice, the process is considered to be EBQI (Melnyk & Fineholt-
Overholt, 2011).  The definition of EBP is best explained by using a “life-long learning approach 
to clinical decision-making that involves the conscientious use of the best available evidence 
(including a systematic search or and critical appraisal of the most relevant evidence to answer a 
clinical question) with one’s own clinical expertise and patient values and preferences to 
improve outcomes for individuals, groups, communities, and systems” (Melnyk & Fineholt-
Overholt, 2011, p. 575).   
Clinical expertise of this DNP student has been developed by practicing for the past 13 
years as an Advanced Practice Registered Nurse (APRN) as a Board Certified Family Nurse 
Practitioner (BC-FNP) in the out-patient system setting.  This DNP student’s clinical 
concentration and specific interests are with the COPD patient population.  As a provider who 
has seen hundreds of new consult AECOPD patients in an out-patient setting, internal evidence 
suggests that COPD is immediately treatable and AECOPD hospitalizations are preventable in 
the out-patient setting, when Level I EBP GOLD guidelines treatments are implemented.  
Sample 
 The sample for this DNP Project consisted of a subset of 120 patients, as a convenience 
sample of the practice’s COPD patient population accessibility and the short time frame to 
complete the project (Stommel & Wills, 2004).  The inclusion criteria were patients with a 
diagnosis of COPD and ICD-9 code of 496, were between the ages of 40 and 89.  GOLD 
classifications II, III, and IV, which were included in the retrospective EHR chart review and all 
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GOLD classification I patients (FEV1 >80%), were excluded upon initial query.  The EHR 
utilized was the AtheanaNet system at the DNP student’s out-patient pulmonary specialty 
practice from an ICD-9 code 496 diagnosis list of over 1200 patients, upon initial query.  A 
unique patient identifier number between 1and 120 was assigned to each COPD patient audited.  
The use of the unique identifier was used to avoid access to and reporting of personal 
information from the electronic health record.      
Methods 
This DNP student’s EBQI Project attained a QI “Exempt” designation from this 
midwestern academic university’s IRB. Both the pulmonologist/practice owner and the office 
manager (Atheana Manager) provided written permission to allow the employed APRN/BC-FNP 
and this DNP student to collect data for this EBQI project.  The project location was in an 
outpatient pulmonary specialty practice located in southwestern Ohio.     
Personal health information (PHI) was accessed to only identify the COPD disease 
population convenience group.  No PHI was collected or recorded as part of this DNP project. A 
unique patient identifier number (1-120) was assigned to each patient to protect their identities 
and to separate and remove PHI from the EHR data collection process. The DNP student’s out-
patient practice’s practice manager acted as the “honest broker” and liaison for the AtheanaNet 
EHR system.  The AtheanaNet EHR system was purchased by the pulmonary practice three 
years prior to the data collection and the COPD GOLD Guideline treatment components queried, 
if followed, were already documented within different aspects of each patient’s office visit.   
A convenience sample of 120 COPD patients with either GOLD class II, III, and/or IV 
disease severity was obtained via retrospective chart auditing.  Each patient record that met 
OUT-PATIENT PRACTICE USE OF GOLD GUIDELINES 22 
criteria for inclusion was assigned a unique patient identifier.  The level of disease severity was 
obtained by reviewing each sample patient’s most recent post-bronchodilator spirometry. 
PFT GOLD Classification (Based on Post-Bronchodilator FEV1) 
In Patients with FEV1/FVC <70% 
 GOLD I:  Mild COPD FEV1>80% predicted 
 GOLD II:  Moderate COPD 50% FEV1 < 80% predicted (start of qualification for 
pulmonary rehabilitation). 
 GOLD III:  Severe COPD 30% FEV1 < 50% predicted  
 GOLD IV:  Very Severe COPD FEV1 < 30% predicted 
The above GOLD criteria, was then queried through each patient’s office visit(s) by the DNP 
student who is an APRN who has specialized in treating COPD since 2003.  The COPD GOLD 
guidelines audit was strictly managed by only this DNP student by reviewing the progress notes 
in the EHR.  The COPD ICD-9 diagnosis code 496 was entered into the AthenaNet EHR data 
base to query a three year period of October 1st, 2012, through September 30th, 2015.  The 
diagnosis of COPD is made during the initial out-patient pulmonary patient consult and 
spirometry testing. 
Data Collection Instrument 
A single spreadsheet was created and utilized for data collection.  This was derived by the 
DNP student for extracting data regarding the GOLD Guideline treatment recommendations.  
Demographic variables included gender, ethnicity, and payer source. Documentation of 
implementation of the GOLD guideline treatment recommendations was then assessed for each 
unique patient number and documented on the spreadsheet.  (Table 1).    
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Table 1:  Audit Tracking Sheet (ATS) 
Pt # Gold Stage II-
IV 
Sex Age Ethnicity Smoker/Ex-
Smoker/Addressed 
ICS/LABA ICS LABA P Vacc Flu Vacc Pulm 
Rehab 
            
1            
2            
3            
4            
5            
…            
120            
 
Data analysis 
An EHR audit of pulmonary function testing was completed to classify patients’ COPD 
stages of I to IV.  Data consisting of the COPD GOLD guideline treatment recommendations 
were evaluated by query of total patients who had all, part, or none of the components 
implemented in their previous treatment plans. The descriptive data findings will be utilized for a 
future quality improvement Practice Change project within the pulmonary practice.  
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Chapter 4:  Findings 
Results 
 This DNP EBP QI project utilized retrospective patient data from AtheanaNet EHRs 
within the out-patient pulmonary practice for the previous three years leading up to the start of 
planned data collection.  The data collected by the DNP Student was for the purposes of 
evaluating use of the GOLD guidelines in 120 COPD practice patients with GOLD II-IV disease 
from October 1st, 2012 to October 1st, 2015.  A three year data collection limitation was chosen, 
to eliminate the need to review data from paper charts, which were utilized prior to the start of 
the pulmonary practice’s initiation and use of AtheanaNet system for EHRs.  
      The convenience sampling was attained from a three year query sample of greater than 
1200 COPD patients.  In order to provide a practical and obtainable goal for the project time 
frame, the convenience sample of 120 patients was recommended by the DNP student’s advisory 
committee members and internal expertise.  The patients were listed by age and therefore, every 
15th to 20th patient’s data was highlighted for inclusion in the convenience sample.  Many 
patients were originally excluded from the sample because they were found to have a missing 
original Pulmonary Function Testing (PFT) for FEV1/FEVC ratios which also provided the 
original post-bronchodilator FEV1 for evaluation of the severity of COPD stages I through IV.  
These exclusions occurred, because of their PFT study(s) being completed prior to the change 
over from paper to the AtheanaNet EHR system.  Several patients were also excluded due to 
their mild stage of disease (GOLD I) or post-bronchodilator FEV1 >80%.  After the exclusions 
were found and a completion of the first random selection for a convenience sample, 
approximately 102 patients were chosen.  Therefore, a second random selection throughout the 
list was made to find another 18 patients for a total convenience sample goal of 120 patients.  
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Demographic Description 
There were a total of 61 females, or 50.8% of the sample, and 59 males, or 49.2% of the 
sample.  Ethnic differences included 111 Caucasians (92.5%), and eight African Americans 
(6.7%).   One subject’s ethnicity was missing from the EHR, making up the remaining 0.8% of 
the sample.  Payer source for this COPD population was also queried for inclusion in this project 
with 23 patients within the sample having private pay insurance (19.9%).  Patients who were in 
federally funded programs and receiving Medicaid and Medicaid funded programs such as 
Buckeye, Molina, and Caresource totaled 30 subjects (25%).  The rest of the sample patients 
(54.3%) had Medicare or Medicare supplemental plans as a payer source and only one patient 
sought treatment as a self-pay patient, representing only 0.8%.  
GOLD Related Variables 
 Out of the 120 convenience sample patients queried, age ranges of these patients were 
between 40 and 89, with a mean age of 64.83 and a median age of 66 years old.  Levels of 
severity of COPD in this sample ranged from 70 GOLD Stage II patients, which represented 
58.3%, 40 GOLD Stage III patients or 33.3%, and 10 GOLD Stage IV patients or 8.3%.   
 Smoking status was documented on the spreadsheet.  A larger number of patients were 
listed as ex-smokers making up 73 or 61.9% of the sample, and 45 patients were listed as current 
smokers, making up 38.1% of the sample.  However, all 120 patients had documentation of the 
GOLD recommendations of addressing smoking at every visit, including cessation counseling, 
and treatment options.   
 Prescription related GOLD treatment recommendations, specifying use of  a short acting 
broncho-dilator (SABA), were provided to 100% of the sample patients.  Prescribed anti-
cholinergic inhalers (LAMAs) were provided to 112 patients, for a total of 93.3% receiving this 
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treatment, and only eight patients did not receive this prescription for a total of 6.7%.  Patients 
who did not receive this treatment did not have a cause listed for why the prescription was not 
provided.  Possible reasons the prescriptions were not provided could include refusal  of the 
prescriptions by the patient, contraindications to the use of LAMA’s, and/or cost to obtain and 
use the prescription.   
 Other pharmacological GOLD treatment recommendations were the appropriate GOLD 
stage and symptom use of an inhaled corticosteroid/long acting beta agonist (ICS/LABA) or 
separate prescriptions of just the ICS or the LABA.  The ICS/LABA combination was prescribed 
by the provider(s) to 111 patients (92.5%), and nine of the sample patients (7.5%), did not 
receive these prescriptions for unknown reasons previously discussed.  A very small number of 
sample patients were prescribed an ICS alone (15) and only two patients were prescribed a 
LABA alone.   
 Both pneumococcal vaccine and influenza vaccines are other recommended GOLD 
guideline treatments.  A total of 65 pneumococcal vaccinated patients make up only 55.1% of the 
sample, with 53 or 44.9% of sample patients who had not received the recommended injection 
and/or had their vaccines up to date.  Patients who received their yearly influenza vaccine totaled 
75 (63.9%), with 43 of the sample patients (36.1%), not receiving or having up to date 
recommended vaccination(s).   
 Pulmonary rehabilitation is considered a treatment recommendation by the GOLD 
guidelines after a patient reaches GOLD Stage II or higher.  Sample patients who were 
prescribed and obtained, or who were currently obtaining pulmonary rehabilitation totaled 44 
with a sample percentage of 36.7%, with 75 of the patients (62.5%), not receiving this GOLD 
treatment recommendation.  This DNP student was unable to ascertain whether the younger 
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and/or less severe, more active patients were performing individual exercise (20 minutes of 
walking activity every day).  Oftentimes, the cost and availability of pulmonary rehabilitation 
programs are considered to be factors related to enrollment in PR vs. individual exercise.  
 Finally, the out-patient pulmonary practice providers were able to meet overall GOLD 
treatment recommendations discussed within this project 80% of the time.  Patients who received 
all of the treatment recommendations represented 20% or 24 of the 120 patients whose EHRs 
were queried for this project.  Patients who had AECOPD in either group were not queried, due 
to the recommendations from the DNP student’s committee members, in order to expedite this 
EBQI project.   
 Upon completion of this retrospective data convenience sampling for use of GOLD 
guidelines treatment recommendations in an out-patient pulmonary practice, several conclusions 
are evident on the Descriptive Summary for Out-Patient Practice Use of GOLD Guidelines 
(Table 2). 
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Table 2:  Descriptive Summary for Out-Patient Practice Use of GOLD Guidelines 
(N=120) 
Variable Response Frequency Percent 
GOLD Stage  II 
III 
IV 
70 
40 
10 
58.3% 
33.3% 
8.3% 
Meets GOLD Smoking 
Counseling and Treatment at 
Each Visit 
YES 
 
120  
100% 
 
Meets GOLD Anticholinergic 
Treatment for Stage 
 
YES 
NO 
 
112 
8 
 
93.3% 
6.7% 
 
Meets GOLD ICS/LABA 
Treatment for Stage 
 
YES 
NO 
 
111 
9 
 
92.5% 
7.5% 
 
Meets GOLD Flu Vaccination 
 
YES 
NO 
 
76 
44 
 
63.3% 
36.7% 
 
Meets GOLD Pneumococcal 
Vaccination 
 
YES 
NO 
 
67 
53 
 
55.8% 
44.2% 
 
Meets GOLD Pulmonary 
Rehabilitation 
 
YES 
NO 
 
45 
75 
 
37.5% 
62.5% 
 
Provider Met GOLD 
Treatment Recommendations 
 
Partially 
 
ALL 
 
96 
 
24 
 
80.0% 
 
20.0% 
Legend: GOLD=Global obstructive lung disease; ICS/LABA=inhaled corticosteroid/long-acting 
bronchodilator 
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Chapter 5:  Summary 
Discussion 
   All GOLD stages II, III, and IV patients were prescribed partial or complete use of 
GOLD guidelines treatment recommendations from several practice providers.  All actively 
smoking patients received smoking cessation counseling at each visit.  All current smokers were 
also offered treatment options and/or prescription therapies for complete cessation.   
Greater than 90% of the patients were provided recommended prescription medications, 
appropriate for their GOLD disease stage.  However, it is unknown whether the other 10% of 
patients were unable to afford medications, refused medications, or had contraindications to its 
use, due to co-morbidities and/or therapies. 
 Areas of GOLD guideline treatment discrepancies by the pulmonary providers were a 
lack of documented and up to date influenza and/or pneumococcal vaccinations.  A larger 
number of patients received influenza vaccinations compared to pneumococcal vaccinations.  
Although patients were highly encouraged to obtain these vaccinations, ultimately it was up to 
the patient in our setting to participate in this GOLD treatment recommendation.  A possible 
reason is the lack of access to influenza and or pneumonia vaccines at the pulmonary practice 
site.  Instead, the patients are instructed to seek these vaccines from their primary care provider 
or an area Pharmacy.  
 The largest finding on this descriptive summary for GOLD treatment recommendation 
was the lack of patients who had previous or current pulmonary rehabilitation.  Even though 
GOLD treatment recommendations for pulmonary rehab are for GOLD stage II and higher, some 
of these GOLD stage II patients may have issues with the cost and a private pay source 
(copayment), or lack of transportation to the facility.  Other conceivable factors that may have 
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prevented a referral for pulmonary rehabilitation  involved those patients with less severe  GOLD 
stage II who were not limited with their daily activity and were able to complete  a daily walking 
routine of greater than 20 minutes to decrease breathlessness.  Documentation of opting out of 
PR referral would clarify rationale for the low PR referral noted in the EHR.  
EBQI Project Summary 
 The overall goal for this EBQI DNP Project was to assess whether COPD GOLD II, III, 
and IV guidelines treatment recommendations are consistently used by providers in an out-
patient pulmonary practice.  The descriptive findings provided implications for a future EBP 
Practice Change within the out-patient pulmonary practice.  The Iowa Model provides this 
guidance and steps for a Practice Change when initial findings within the practice provide 
sufficient evidence of a gap between theory and practice.  
Significance of the Findings 
 This EBQI Project’s findings were able to show that providers overall, were able to 
achieve an appropriate use of medications (Anti-cholinergic/LAMA, ICS, LAMA, and 
ICS/LABA) for GOLD stage treatment recommendations.   Also, providers within this practice 
were 100% consistent with GOLD guideline treatment recommendation to address smoking 
cessation and offer nicotine replacement therapy or other prescriptions to aid in desired 
cessation.  Such interventions were well documented at each visit.   
These findings also reveal a lack of consistent use of several of the GOLD treatment 
recommendations for implementation of pneumococcal vaccinations, influenza vaccinations, and 
a low incidence of referral for pulmonary rehabilitation by the practice.  There is also a lack of 
documentation in the patient’s EHR related to the low vaccination rates but could include patient 
refusal, contraindications, or cost associated.     
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Implications for Future Practice Change 
The improvement of chronic care management (CCM) of COPD disease within the out-
patient care setting has shown improved quality of life and decreased AECOPD (Lemmens et al., 
2013, p. 734).  Providing and/or improving utilization of GOLD guideline treatment with each 
guideline every time with every COPD patient would be insured by the use of an out-patient 
COPD Care Bundle (Table 3).   
Table 3:  COPD Out-patient Care Bundle: 
 
GOLD 
(FEV1)___% 
            I  __ 
           II  __ 
          III __ 
          IV __ 
 
AECOPD 
DATE  ______ 
Site    _______ 
 
     
 
Smoking Status 
 
Current  ___ 
Pack/day___ 
Years     ___ 
 
Addressed 
Yes      ___ 
No       ___ 
 
RX_________ 
 
Quit 
(year)___ 
 
 
 
 
 
Pharmacologic 
 
 
LAMA    ___ 
 
 
ICS/LABA__ 
 
 
LAMA/LABA___ 
 
 
ICS  ____ 
 
 
LABA  ____ 
 
 
Pulmonary 
Rehab 
 
Qualifies ___ 
Refused  ___ 
 
Self        ___ 
(20 minutes 
daily walking) 
 
Counseled __ 
 
Referred PR____ 
Site   _______ 
   
       
       
 
Care Bundles are identified by the Institute for Health Care Improvement (IHI) to 
“deliver the best possible care for patients” with three to five Level I Evidence Based Practices 
(EBP) that are followed together as a group for all patients every time (Haraden, 2014, p. 1).  
These (CBs) include evidence based actions that are performed consistently, every time, and are 
proven to improve patient care and outcomes (Haraden, 2014).  Therefore, this proposed future 
EB Practice Change is needed at the out-patient pulmonary practice to improve Level I EBP 
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compliance for COPD patients to prevent acute exacerbation(s), which decrease COPD patients’ 
quality of life and longevity.   
A future EBQI project will include a retrospective data collection for a specific time 
frame of at least one year since the start of the GOLD guidelines CB creation.  The results of the 
outcomes of the future DNP project would then establish improved outcomes for COPD patients 
such as appropriate medication use, increased PR referrals, reduction is number of 
hospitalizations and re-hospitalizations.  
The Iowa Model of Evidence-Based Practice to Promote Quality Care (Appendix A), will 
be utilized for guidance to pilot the change into practice. Additionally, continued quality of care 
processes, literature query for new knowledge, and disseminating the outcomes and results data 
will be used to drive care process changes. The outpatient Care Bundle for COPD, once found to 
be a cost-effective and beneficial Practice Change, can then be disseminated for use in any out-
patient practice for use to improve COPD patient diagnosis, treatment, and improved outcomes. 
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Appendix A: The Iowa Model of Evidence Based Practice to Promote Quality Care  
 
Used/Reprinted with permission from the University of Iowa Hospitals and Clinics. Copyright 2015. For permission to use or 
reproduce the model, please contact the University of Iowa Hospitals and Clinics at (319)384-9098. 
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Appendix B:  Health Change Trajectory Model 
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